Lista de obras - Monika Rau - Dominio Público Uruguay

A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients - single-center real-world experience of outpatient clinical practice

artículo científico publicado en 2019

Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers

artículo científico publicado en 2013

Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.

artículo científico publicado en 2016

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

artículo científico publicado en 2018

Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease

artículo científico publicado en 2017

Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis

artículo científico publicado en 2010

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

artículo científico publicado en 2016

Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers

scientific article published on 26 February 2018

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients

artículo científico publicado en 2013

Emerging therapies for NASH - the future is now.

artículo científico publicado en 2017

Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe.

artículo científico publicado en 2016

Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease

artículo científico publicado en 2018

Host genetic variants in the pathogenesis of hepatitis C.

artículo científico publicado en 2012

Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection

artículo científico publicado en 2012

In reply

Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease.

artículo científico

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness

scientific article published on 01 August 2019

Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis

artículo científico publicado en 2017

NAFLD patients scheduled for bariatric surgery present with a milder disease phenotype as compared to not morbidly obese NAFLD patients: analysis of a large real-world cohort

artículo científico publicado en 2022

Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies.

artículo científico publicado en 2016

Non-alcoholic fatty liver disease (NAFLD)

artículo científico publicado en 2015

Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.

artículo científico publicado en 2014

Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective

artículo científico publicado en 2019

Patient with COPD after allogeneic hematopoietic stem cell transplantation with cough and subfebrile temperature

artículo científico publicado en 2014

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.

artículo científico publicado en 2015

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.

artículo científico publicado en 2015

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

artículo científico publicado en 2014

Reply to: “Estimating ribavirin plasma exposure: Genetics or therapeutic drug monitoring?” ⬇️

artículo científico publicado el 23 de mayo de 2013

Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients

artículo científico publicado en 2018

The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm

artículo científico publicado en 2017

Thrombophlebitis der Vena basilica nach beidseitiger Brustaugmentation

artículo científico publicado en 2017

[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology].

artículo científico publicado en 2015

[Successful Antibiotic Treatment of Lumbar Pain]

scientific article published on 01 April 2018

Lista de obras de Monika Rau

A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients - single-center real-world experience of outpatient clinical practice

Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers

Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease

Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients

Emerging therapies for NASH - the future is now.

Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe.

Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease

Host genetic variants in the pathogenesis of hepatitis C.

Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection

In reply

Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease.

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness

Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis

NAFLD patients scheduled for bariatric surgery present with a milder disease phenotype as compared to not morbidly obese NAFLD patients: analysis of a large real-world cohort

Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies.

Non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.

Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective

Patient with COPD after allogeneic hematopoietic stem cell transplantation with cough and subfebrile temperature

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

Reply to: “Estimating ribavirin plasma exposure: Genetics or therapeutic drug monitoring?” ⬇️

Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients

The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm

Thrombophlebitis der Vena basilica nach beidseitiger Brustaugmentation

[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology].

[Successful Antibiotic Treatment of Lumbar Pain]